MARKET

RIGL

RIGL

Rigel Pharmaceuticals Inc
NASDAQ
47.70
-0.43
-0.89%
Opening 14:12 09/24 EDT
OPEN
47.87
PREV CLOSE
48.13
HIGH
47.87
LOW
47.00
VOLUME
51.94K
TURNOVER
--
52 WEEK HIGH
52.24
52 WEEK LOW
24.95
MARKET CAP
891.03M
P/E (TTM)
2.975
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RIGL last week (0914-0918)?
Weekly Report · 3d ago
Weekly Report: what happened at RIGL last week (0907-0911)?
Weekly Report · 09/14 10:20
Analysts Are Bullish on These Healthcare Stocks: Rigel (RIGL), Opus Genetics (IRD)
TipRanks · 09/08 10:30
Weekly Report: what happened at RIGL last week (0831-0904)?
Weekly Report · 09/07 10:13
Weekly Report: what happened at RIGL last week (0824-0828)?
Weekly Report · 08/31 10:20
Weekly Report: what happened at RIGL last week (0817-0821)?
Weekly Report · 08/24 10:21
X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade)
Seeking Alpha · 08/19 08:14
Rigel Pharmaceuticals Is Maintained at Neutral by Piper Sandler
Dow Jones · 08/17 16:23
More
About RIGL
Rigel Pharmaceuticals, Inc. is a biotechnology company. The Company is engaged in developing and providing therapies for patients with hematologic disorders and cancer. It focuses on products that address signaling pathways that are critical to disease mechanisms. Its products include TAVALISSE, REZLIDHIA, and GAVRETO. TAVALISSE is an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. REZLIDHIA is used for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. GAVRETO is a once daily, small molecule, oral, kinase inhibitor of wild type rearranged during transfection (RET) and oncogenic RET fusions. It is used for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory.

Webull offers Rigel Pharmaceuticals Inc stock information, including NASDAQ: RIGL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RIGL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RIGL stock methods without spending real money on the virtual paper trading platform.